1 Min Read
Sept 19 (Reuters) - Agilent Technologies Inc:
* Says FDA approved cancer diagnostic for use in cases of UC and of Squamous Cell Carcinoma of head & neck Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.